BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Clinical Outcome
6 results:

  • 1. Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytes.
    Kelley MB; Geddes TJ; Ochiai M; Lampl NM; Kothmann WW; Fierstein SR; Kent V; DeCicco-Skinner K
    PLoS One; 2022; 17(3):e0266017. PubMed ID: 35325006
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Favorable outcome with Close Margins in Patients Undergoing Nipple/skin Sparing Mastectomy with Immediate Breast Reconstruction: 5-year Follow-up.
    Özkurt E; Tükenmez M; Güven E; Çelet Özden B; Öner G; Müslümanoğlu M; İğci A; Özmen V; Küçücük S; Cabioğlu N
    Balkan Med J; 2018 Jan; 35(1):84-92. PubMed ID: 28958980
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival.
    Tarhan MO; Demir L; Somali I; Yigit S; Erten C; Alacacioglu A; Ellidokuz H; Seseogullari O; Kucukzeybek Y; Can A; Dirican A; Bayoglu V; Akyol M
    Clin Exp Metastasis; 2013 Feb; 30(2):201-13. PubMed ID: 22915160
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction.
    Wainberg ZA; Lin LS; DiCarlo B; Dao KM; Patel R; Park DJ; Wang HJ; Elashoff R; Ryba N; Hecht JR
    Br J Cancer; 2011 Sep; 105(6):760-5. PubMed ID: 21811258
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nuclear HER3 is associated with favorable overall survival in uveal melanoma.
    Trocmé E; Mougiakakos D; Johansson CC; All-Eriksson C; Economou MA; Larsson O; Seregard S; Kiessling R; Lin Y
    Int J Cancer; 2012 Mar; 130(5):1120-7. PubMed ID: 21484789
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Extramammary Paget's disease: analysis of growth signal pathway from the human epidermal growth factor receptor 2 protein.
    Ogawa T; Nagashima Y; Wada H; Akimoto K; Chiba Y; Nagatani T; Inayama Y; Yao M; Aoki I; Ikezawa Z
    Hum Pathol; 2005 Dec; 36(12):1273-80. PubMed ID: 16311120
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.